United States · FDA National Drug Code directory
Zirabev
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0342_8f385b9e-2699-46a0-8c5f-ec1d86cd609d
- Product NDC
- 0069-0342
- Form
- INJECTION, SOLUTION
- Composition / generic term
- bevacizumab-bvzr
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200113
- Source listing expiry
- 20271231
Source-listed ingredients
- BEVACIZUMAB — 400 mg/16mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0069-0342-01) / 16 mL in 1 VIAL, SINGLE-USE · 0069-0342-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →